4.7 Article

p62 overexpression induces TDP-43 cytoplasmic mislocalisation, aggregation and cleavage and neuronal death

Journal

SCIENTIFIC REPORTS
Volume 11, Issue 1, Pages -

Publisher

NATURE RESEARCH
DOI: 10.1038/s41598-021-90822-2

Keywords

-

Funding

  1. National Health and Medical Research Council of Australia [APP1102977]
  2. Motor Neuron Disease Research Australia/Muscular Dystrophy of Western Australia [IG 1949]

Ask authors/readers for more resources

The study found that overexpression of p62 leads to mislocalization of TDP-43 into cytoplasmic aggregates, aberrant TDP-43 cleavage, and neuronal death, potentially contributing to the pathogenesis of ALS and FTLD.
Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) that exist on a spectrum of neurodegenerative disease. A hallmark of pathology is cytoplasmic TDP-43 aggregates within neurons, observed in 97% of ALS cases and similar to 50% of FTLD cases. This mislocalisation from the nucleus into the cytoplasm and TDP-43 cleavage are associated with pathology, however, the drivers of these changes are unknown. p62 is invariably also present within these aggregates. We show that p62 overexpression causes TDP-43 mislocalisation into cytoplasmic aggregates, and aberrant TDP-43 cleavage that was dependent on both the PB1 and ubiquitin-associated (UBA) domains of p62. We further show that p62 overexpression induces neuron death. We found that stressors (proteasome inhibition and arsenic) increased p62 expression and that this shifted the nuclear:cytoplasmic TDP-43 ratio. Overall, our study suggests that environmental factors that increase p62 may thereby contribute to TDP-43 pathology in ALS and FTLD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Medicine, General & Internal

Short structural variants as informative genetic markers for ALS disease risk and progression

Frances Theunissen, Loren L. Flynn, Ryan S. Anderton, P. Anthony Akkari

Summary: This article discusses the role of recent discoveries of short structural variations (SSVs) in ALS and how these findings can be applied to future clinical trials. These discoveries help reduce participant heterogeneity and improve outcomes of ALS clinical trials.

BMC MEDICINE (2022)

Article Neurosciences

TDP-43 is a ubiquitylation substrate of the SCFcyclin F complex

Stephanie L. Rayner, Shu Yang, Natalie E. Farrawell, Cyril J. Jagaraj, Flora Cheng, Jennilee M. Davidson, Luan Luu, Alberto G. Redondo, Alberto Rabano, Daniel Borrego-Hernandez, Julie D. Atkin, Marco Morsch, Ian P. Blair, Justin J. Yerbury, Roger Chung, Albert Lee

Summary: This study reveals a direct ubiquitylation mechanism for TDP-43 mediated by cyclin F, providing important insights into the regulation of cyclin F-mediated TDP-43 turnover and clues towards understanding the molecular origins of the ubiquitylated TDP-43 inclusions that are the hallmark feature in ALS and FTD.

NEUROBIOLOGY OF DISEASE (2022)

Article Genetics & Heredity

Single Stranded Fully Modified-Phosphorothioate Oligonucleotides can Induce Structured Nuclear Inclusions, Alter Nuclear Protein Localization and Disturb the Transcriptome In Vitro

Loren L. Flynn, Ruohan Li, Ianthe L. Pitout, May T. Aung-Htut, Leon M. Larcher, Jack A. L. Cooper, Kane L. Greer, Alysia Hubbard, Lisa Griffiths, Charles S. Bond, Steve D. Wilton, Archa H. Fox, Sue Fletcher

Summary: Modified oligonucleotides and nucleic acid analogues have potential therapeutic applications in human disease. However, the modifications may have unexpected effects on physicochemical and biological properties. This study reveals the chemistry-specific effects of modified or unmodified oligonucleotides with phosphorothioate linkages on subnuclear organelles, nuclear protein distribution, nuclear inclusions, and RNA processing in primary human fibroblasts and other cultured cells.

FRONTIERS IN GENETICS (2022)

Article Biochemistry & Molecular Biology

Inter-Regional Proteomic Profiling of the Human Brain Using an Optimized Protein Extraction Method from Formalin-Fixed Tissue to Identify Signaling Pathways

Jennilee M. Davidson, Stephanie L. Rayner, Sidong Liu, Flora Cheng, Antonio Di Ieva, Roger S. Chung, Albert Lee

Summary: Proteomics has great potential in studying the molecular regulation of the human brain. This study compared the efficiency of two different protein-extraction buffers on formalin-fixed human brains, and found that a lysis buffer containing TrisHCl, SDS, SDC, and Triton X-100 had superior protein extraction performance. The analysis also revealed differential enrichment of proteins in different brain regions, indicating commonalities in the molecular regulation of neuroanatomically-linked brain functions. Overall, the study developed an optimized method for protein extraction from formalin-fixed human brain tissue and demonstrated its suitability for rapid and routine analysis of molecular signaling pathways in the human brain.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Identification of phosphorylated tau protein interactors in progressive supranuclear palsy (PSP) reveals networks involved in protein degradation, stress response, cytoskeletal dynamics, metabolic processes, and neurotransmission

Rowan A. W. Radford, Stephanie L. Rayner, Paulina Szwaja, Marco Morsch, Flora Cheng, Tianyi Zhu, Jocelyn Widagdo, Victor Anggono, Dean L. Pountney, Roger Chung, Albert Lee

Summary: Progressive supranuclear palsy (PSP) is a neurodegenerative disease characterized by the presence of insoluble phosphorylated-Tau (p-Tau) in neurons and glia. In this study, a proteomic approach using antibody-mediated biotinylation and mass spectrometry (MS) was used to identify proteins near p-Tau inclusions in PSP. The results showed the presence of previously identified interacting proteins of Tau and known modifiers of Tau aggregation, as well as 19 novel proteins associated with Tau. Additionally, the study found proteins related to neurological disorders and pathways involved in various cellular processes.

JOURNAL OF NEUROCHEMISTRY (2023)

Article Neurosciences

The E3 Ubiquitin Ligase SCF Cyclin F Promotes Sequestosome-1/p62 Insolubility and Foci Formation and is Dysregulated in ALS and FTD Pathogenesis

Jennilee M. Davidson, Sharlynn S. L. Wu, Stephanie L. Rayner, Flora Cheng, Kimberley Duncan, Carlo Russo, Michelle Newbery, Kunjie Ding, Natalie M. Scherer, Rachelle Balez, Alberto Garcia-Redondo, Alberto Rabano, Livia Rosa-Fernandes, Lezanne Ooi, Kelly L. Williams, Marco Morsch, Ian P. Blair, Antonio Di Ieva, Shu Yang, Roger S. Chung, Albert Lee

Summary: This study reveals the role of cyclin F in regulating substrate solubility and its contribution to the pathogenesis of ALS and FTD. The ALS and FTD-associated protein p62 is identified as a substrate of cyclin F, and its aggregation is promoted by cyclin F expression. Mutations in cyclin F result in dysregulated p62 solubility and formation of p62 foci, which are associated with ALS and FTD pathogenesis.

MOLECULAR NEUROBIOLOGY (2023)

Editorial Material Biochemical Research Methods

How can proteomics help solve the lack of biomarkers to aid in the early diagnosis of motor neuron disease (MND)?

Hannah Jane Suddull, Livia Rosa-Fernandes, Albert Lee

EXPERT REVIEW OF PROTEOMICS (2023)

Article Clinical Neurology

RNA sequencing of peripheral blood in amyotrophic lateral sclerosis reveals distinct molecular subtypes: Considerations for biomarker discovery

Natalie Grima, Sidong Liu, Dean Southwood, Lyndal Henden, Andrew Smith, Albert Lee, Dominic B. Rowe, Susan D'Silva, Ian P. Blair, Kelly L. Williams

Summary: Peripheral blood RNA-seq can identify diagnostic biomarkers in ALS patients and distinguish molecular subtypes, but its prognostic value needs further investigation.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2023)

Meeting Abstract Rheumatology

A SQSTM1 POLYMORPHISM CONFERS RISK FOR SPORADIC INCLUSION BODY MYOSITIS DISEASE EXPRESSION

Julia Pytte, Maria Van Loenhout, Frank Mastaglia, Ian James, Loren L. Flynn, Gabriella MacDougall, Kelly Beer, Jerome Coudert, Anu Sooda, P. Anthony Akkari, Merilee Needham

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (2023)

Review Cell Biology

TDP-43 as a therapeutic target in neurodegenerative diseases: Focusing on motor neuron disease and frontotemporal dementia

Afshin Babazadeh, Stephanie L. Rayner, Albert Lee, Roger S. Chung

Summary: A common feature of adult-onset neurodegenerative diseases is the presence of specific pathological protein accumulations. Restoring protein homeostasis of these accumulations may represent a potential therapeutic strategy. This review discusses the mechanisms leading to disrupted protein homeostasis and explores small molecule-based therapies for modulating these mechanisms.

AGEING RESEARCH REVIEWS (2023)

No Data Available